Legal & General Takeover Buzz Jolts FTSE 100 Stock As CEO Says No Sale Is On The Table

Legal & General Takeover Buzz Jolts FTSE 100 Stock As CEO Says No Sale Is On The Table

May 15, 2026

LONDON, May 15, 2026, 13:10 BST

Legal & General Group Plc shares barely budged in London on Friday, sticking near Thursday’s sharp gain. Takeover chatter continued to swirl around the FTSE 100 insurer and asset manager, despite Chief Executive António Simões insisting the company isn’t weighing a sale or a break-up.

Early Friday afternoon, shares changed hands at 263.10p on the offer and 263.20p on the bid, slipping 0.27% after Thursday’s 6.16% jump. AJ Bell pegged Legal & General’s market cap near 14.56 billion pounds.

This isn’t just about L&G. The company is now at the center of a broader debate in London’s financial circles—can big UK insurers, those with annuity portfolios, asset-management businesses, and reliable dividends, hold their appeal as public companies with private-capital investors increasingly targeting pension assets?

L&G shares jumped over 5% on Thursday, Reuters said, after the Financial Times flagged growing takeover chatter. An L&G spokesperson wouldn’t comment on the FT story, Reuters added.

Simões was blunt, telling the FT there’s “no discussions or anything else going on.” Sharecast reported that when pressed about whether L&G had fielded any approaches, he responded: “I am 100% focused on executing my strategy.” Sharecast

Investors are still weighing that strategy. Back in March, L&G reported 2025 core operating profit up 6% to 1.62 billion pounds. The company also put its pro forma Solvency II coverage ratio at 210%, and pledged to return over 5 billion pounds to shareholders from 2025 through 2027. Solvency II refers to the capital-strength yardstick insurers use.

Doubts lingered after the March update. Morningstar, referencing Alliance News, noted L&G’s solvency ratio came in below Visible Alpha consensus, with RBC Capital Markets analysts labelling the shortfall “significant.” L&G marked down asset values by 304 million pounds, pointing to the drag from higher discount rates on certain holdings. Morningstar

Pension risk transfer—PRT for short—takes the spotlight here. Under these arrangements, insurers assume some or all of a company’s pension obligations, for a set premium. L&G logged global PRT volumes of 11.8 billion pounds for 2025, with 10.4 billion coming from the UK.

The landscape is heating up. On April 1, Brookfield Wealth Solutions wrapped up its £2.4 billion buyout of Just Group, saying the company has room to grow in the UK pension risk transfer space. Brookfield pegged annual liability transfers to insurers at anywhere from £40 billion to £50 billion.

In March, Athora—backed by Apollo—wrapped up its takeover of Pension Insurance Corporation Group. That deal makes PIC Athora’s UK insurance arm and hands the group more long-term capital and asset-origination firepower. For L&G, it means yet another heavyweight, private-capital-backed rival has arrived on their patch.

Rates remain in play. On Kalshi, traders were pricing in an 80% probability that the Bank of England holds steady in June, with a 16% chance seen for a hike of 1-25 basis points. Polymarket’s odds leaned even more toward no move—88% for no change and 12% for a 25-basis-point hike ahead of the June 18 meeting. Remember, one basis point equals one-hundredth of a percentage point.

The risk is clear enough. A full buyout faces political hurdles and regulatory scrutiny—L&G holds plenty of gilts, or UK government bonds, as the FT has reported. If rates climb, credit risk worsens, or annuity margins narrow, those pressure points could put the firm’s dividend and buyback strategy on shakier ground.

At this stage, L&G isn’t running a sale process—just heightened chatter among market watchers. Investors looking for updates won’t have long to wait: the company’s annual general meeting and general meeting are both scheduled for May 21.

Stock Market Today

  • RocketDNA Acquires Full Stake in WA Subsidiary to Simplify Structure
    June 17, 2026, 12:12 AM EDT. RocketDNA (ASX: RKT) announced it will acquire the remaining 40% stake in its Western Australia subsidiary for $1 million in shares, equivalent to about 3.5% of issued capital. The acquisition streamlines the group by eliminating minority interests. Shares for the transaction will be issued at the 20-day volume weighted average price of $0.024 each. Founders and key team members, including technical director Evan McKern and co-founder Shane McLeay, are part of vendors receiving shares held in escrow for 12 months. RocketDNA already controls the subsidiary, which generated most Australian revenue, so no operational impact is expected. The move follows a strong quarter with the company posting its first positive operating cash flow and 49% revenue growth year-on-year. Completion depends on customary conditions including loan amendments.